Van Veen JJ - Search Results

1

Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.

Bowyer AE, Van Veen JJ, Goodeve AC, Kitchen S, Makris M. Bowyer AE, et al. Among authors: van veen jj. Haematologica. 2013 Dec;98(12):1980-7. doi: 10.3324/haematol.2013.088088. Epub 2013 Jun 28. Haematologica. 2013. PMID: 23812942 Free PMC article.

2

Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.

van Veen JJ, Gatt A, Cooper PC, Kitchen S, Bowyer AE, Makris M. van Veen JJ, et al. Blood Coagul Fibrinolysis. 2008 Apr;19(3):183-9. doi: 10.1097/MBC.0b013e3282f4bb47. Blood Coagul Fibrinolysis. 2008. PMID: 18388496

3

Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.

Gatt A, van Veen JJ, Woolley AM, Kitchen S, Cooper P, Makris M. Gatt A, et al. Among authors: van veen jj. Thromb Haemost. 2008 Aug;100(2):350-5. Thromb Haemost. 2008. PMID: 18690358

4

Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A.

van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M. van Veen JJ, et al. Thromb Res. 2009 Apr;123(6):895-901. doi: 10.1016/j.thromres.2008.09.011. Epub 2008 Nov 13. Thromb Res. 2009. PMID: 19012951

5

The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents.

van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M. van Veen JJ, et al. Int J Lab Hematol. 2009 Apr;31(2):189-98. doi: 10.1111/j.1751-553X.2007.01022.x. Epub 2008 Jan 9. Int J Lab Hematol. 2009. PMID: 18190585

6

Altitude and coagulation activation: does going high provoke thrombosis?

van Veen JJ, Makris M. van Veen JJ, et al. Acta Haematol. 2008;119(3):156-7. doi: 10.1159/000128045. Epub 2008 Apr 24. Acta Haematol. 2008. PMID: 18434708 Review. No abstract available.

7

The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.

Bowyer A, Smith J, Woolley AM, Kitchen S, Hampton KK, Maclean RM, VAN Veen JJ, Makris M. Bowyer A, et al. Among authors: van veen jj. Int J Lab Hematol. 2011 Apr;33(2):212-8. doi: 10.1111/j.1751-553X.2010.01266.x. Epub 2010 Sep 29. Int J Lab Hematol. 2011. PMID: 20880301

8

Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.

Makris M, van Veen JJ, Maclean R. Makris M, et al. Among authors: van veen jj. J Thromb Thrombolysis. 2010 Feb;29(2):171-81. doi: 10.1007/s11239-009-0412-5. J Thromb Thrombolysis. 2010. PMID: 19882303 Review.

9

Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban.

Guy S, Kitchen S, Van Veen JJ. Guy S, et al. Among authors: van veen jj. Br J Haematol. 2018 Feb;180(4):594-597. doi: 10.1111/bjh.14397. Epub 2016 Oct 26. Br J Haematol. 2018. PMID: 27785784 Free article. No abstract available.

10

Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumab.

Bowyer A, Brown P, Hopkins B, Scully M, Shepherd F, Lowe A, Mensah P, Maclean R, Kitchen S, van Veen JJ. Bowyer A, et al. Among authors: van veen jj. Br J Haematol. 2022 May;197(3):349-358. doi: 10.1111/bjh.18080. Epub 2022 Mar 8. Br J Haematol. 2022. PMID: 35262910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters